Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJQN1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,207
Award facts
- Contract value 100% obligated
- $30,206.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,206.63 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle running through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated strong capability in competitively winning federal contracts across multiple therapeutic categories. The company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible contract vehicles. Dupixent (dupilumab) is a biologic immunosuppressant therapy used primarily to treat moderate-to-severe atopic dermatitis and other allergic conditions, representing specialized pharmaceutical procurement aligned with military medical supply requirements. This delivery order exemplifies the routine pharmaceutical replenishment activities conducted through DLA's established prime vendor network to maintain adequate inventory for servicemembers and military beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FJQN1?
SPE2DB25FJQN1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FJQN1 worth?
The government has obligated $30,207 on SPE2DB25FJQN1.
Is contract SPE2DB25FJQN1 an order under another contract?
Yes. SPE2DB25FJQN1 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJQN1 competed?
The extent of competition for SPE2DB25FJQN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award